Hilltop Holdings’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,428
Closed -$1.32M 535
2020
Q4
$1.32M Buy
1,428
+66
+5% +$69.4K 0.19% 122
2020
Q3
$1.4M Sell
1,362
-60
-4% -$64.6K 0.24% 94
2020
Q2
$1.44M Sell
1,422
-90
-6% -$83.6K 0.27% 90
2020
Q1
$1.31M Sell
1,512
-214
-12% -$213K 0.32% 69
2019
Q4
$1.85M Sell
1,726
-16
-0.9% -$16.3K 0.35% 76
2019
Q3
$1.61M Sell
1,742
-210
-11% -$231K 0.31% 82
2019
Q2
$2.21M Buy
1,952
+196
+11% +$215K 0.47% 52
2019
Q1
$2.39M Buy
1,756
+8
+0.5% +$10.8K 0.51% 49
2018
Q4
$2.02M Sell
1,748
-404
-19% -$454K 0.5% 47
2018
Q3
$3.27M Sell
2,152
-54
-2% -$83.2K 0.69% 32
2018
Q2
$3.45M Buy
2,206
+62
+3% +$80.8K 0.73% 26
2018
Q1
$2.48M Buy
2,144
+701
+49% +$923K 0.43% 53
2017
Q4
$1.71M Sell
1,443
-176
-11% -$221K 0.39% 71
2017
Q3
$2.18M Buy
1,619
+176
+12% +$185K 0.66% 42
2017
Q2
$1.17M Hold
1,443
0.34% 93
2017
Q1
$889K Hold
1,443
0.27% 121
2016
Q4
$772K Hold
1,443
0.24% 125
2016
Q3
$747K Hold
1,443
0.24% 142
2016
Q2
$592K Hold
1,443
0.19% 156
2016
Q1
$768K Hold
1,443
0.24% 132
2015
Q4
$1.1M Hold
1,443
0.32% 102
2015
Q3
$791K Sell
1,443
-516
-26% -$313K 0.23% 134
2015
Q2
$1.15M Buy
1,959
+516
+36% +$300K 0.31% 110
2015
Q1
$1.13M Buy
+1,443
New +$1.12M 0.29% 118

Other funds holding KYNB

Hilltop Holdings's KYNB Position: Q1 2021 in Review

Hilltop Holdings sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 1,428 shares — an estimated $1.32M sold.

Hilltop Holdings first reported a position in KYNB in Q1 2015 and held it in 24 quarters. The position peaked at $3.45M in Q2 2018. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Hilltop Holdings reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Hilltop Holdings sold 1,428 Kyntra Bio shares in Q1 2021, an estimated $1.32M.
  • Hilltop Holdings first reported a position in Kyntra Bio in Q1 2015 and held it in 24 quarters.
  • Hilltop Holdings's Kyntra Bio position peaked at $3.45M in Q2 2018.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Hilltop Holdings's 13F filing for Q1 2021, filed 17 May 2021.